ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Roquefort Therapeutics Plc

Roquefort Therapeutics Plc (ROQ)

4,18
-0,02
(-0,48%)
Geschlossen 04 Januar 5:30PM

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Current Price
4,18
Gebot
3,80
Fragen
4,10
Volumen
848.155
3,95 Tagesbereich 4,25
3,35 52-Wochen-Bereich 9,25
Marktkapitalisierung
Handelsende
4,20
Handelsbeginn
4,20
Letzte Trade
8000
@
4.18
(UT)
Letzter Handelszeitpunkt
Finanzvolumen
35.453p
VWAP
4,18
Durchschnittliches Volumen (3 Mio.)
1.522.272
Ausgegebene Aktien
129.149.998
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-2,93
Gewinn pro Aktie (EPS)
-0,01
Erlöse
200k
Nettogewinn
-1,75M

Über Roquefort Therapeutics Plc

Sektor
Cmp Integrated Sys Design
Branche
Cmp Integrated Sys Design
Hauptsitz
London, Gbr
Gegründet
-
Roquefort Therapeutics Plc is listed in the Cmp Integrated Sys Design sector of the Londoner Börse with ticker ROQ. The last closing price for Roquefort Therapeutics was 4,20p. Over the last year, Roquefort Therapeutics shares have traded in a share price range of 3,35p to 9,25p.

Roquefort Therapeutics currently has 129.149.998 shares in issue. The market capitalisation of Roquefort Therapeutics is £5,42 million. Roquefort Therapeutics has a price to earnings ratio (PE ratio) of -2.93.

ROQ Neueste Nachrichten

Roquefort Therapeutics proposes USD10 million subsidiary sale

Roquefort Therapeutics PLC on Thursday said it has proposed the sale of subsidiary Lyramid Pty Ltd to Pleiades Pharma ...

Roquefort Therapeutics PLC Proposed Sale of Midkine Portfolio

Roquefort Therapeutics PLC 02 January 2025   2 January 2025 Roquefort Therapeutics plc ("Roquefort Therapeutics" or the "Company") Proposed Sale of Midkine Portfolio   Roquefort Therapeutics...

Roquefort Therapeutics PLC Director Share Distribution

Roquefort Therapeutics PLC 04 December 2024   4 December 2024   Roquefort Therapeutics plc ("Roquefort Therapeutics" or the "Company")   Director Share Distribution   Roquefort Therapeutics...

Roquefort Therapeutics PLC Conversion of Convertible Loan Notes

Roquefort Therapeutics PLC 07 November 2024   7 November 2024 Roquefort Therapeutics plc ("Roquefort Therapeutics" or the "Company") Conversion of Convertible Loan Notes   Roquefort...

EARNINGS: Kendrick Resources loss narrows; Emmerson CFO to depart

The following is a round-up of earnings for London-listed companies, issued on Friday and not separately reported by ...

Roquefort Therapeutics PLC Interim Results to 30 June 2024

Roquefort Therapeutics PLC 27 September 2024   27 September 2024 Roquefort Therapeutics plc ("Roquefort Therapeutics" or the "Company")   Interim Results to 30 June 2024   Roquefort...

Roquefort Therapeutics says MK cell therapy patent approved in Japan

Roquefort Therapeutics PLC on Monday announced its patent for mesodermal killer, or MK, cell therapy has been approve ...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.133.209876543214.0553.915516344.13536455DE
40.030.7228915662654.1553.810208524.19371313DE
120.235.822784810133.956.753.615222724.64803292DE
26-0.57-124.756.753.358279744.53720168DE
52-3.07-42.34482758627.259.253.355595114.76287463DE
156-6.32-60.190476190510.511.253.353639096.42840279DE
260-1.82-30.3333333333613.53.352983336.54139613DE

ROQ - Frequently Asked Questions (FAQ)

What is the current Roquefort Therapeutics share price?
The current share price of Roquefort Therapeutics is 4,18p
How many Roquefort Therapeutics shares are in issue?
Roquefort Therapeutics has 129.149.998 shares in issue
What is the market cap of Roquefort Therapeutics?
The market capitalisation of Roquefort Therapeutics is GBP 5,42M
What is the 1 year trading range for Roquefort Therapeutics share price?
Roquefort Therapeutics has traded in the range of 3,35p to 9,25p during the past year
What is the PE ratio of Roquefort Therapeutics?
The price to earnings ratio of Roquefort Therapeutics is -2,93
What is the cash to sales ratio of Roquefort Therapeutics?
The cash to sales ratio of Roquefort Therapeutics is 26,33
What is the reporting currency for Roquefort Therapeutics?
Roquefort Therapeutics reports financial results in GBP
What is the latest annual turnover for Roquefort Therapeutics?
The latest annual turnover of Roquefort Therapeutics is GBP 200k
What is the latest annual profit for Roquefort Therapeutics?
The latest annual profit of Roquefort Therapeutics is GBP -1,75M
What is the registered address of Roquefort Therapeutics?
The registered address for Roquefort Therapeutics is 85 GREAT PORTLAND STREET, FIRST FLOOR, LONDON, W1W 7LT
What is the Roquefort Therapeutics website address?
The website address for Roquefort Therapeutics is www.roquefortplc.com
Which industry sector does Roquefort Therapeutics operate in?
Roquefort Therapeutics operates in the CMP INTEGRATED SYS DESIGN sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
TCFTheracryf Plc
0,725p
(38,10%)
7,56M
NMTNeometals Ltd
3,50p
(27,27%)
346,81k
SCHOScholium Group Plc
44,00p
(25,71%)
30,65k
FABFusion Antibodies Plc
10,15p
(24,54%)
3,34M
PYXPyx Resources Limited
3,49p
(22,24%)
8,43k
TM1Technology Minerals Plc
0,125p
(-24,24%)
37,21M
QUIZQuiz Plc
0,70p
(-18,60%)
3,67M
SYMESupply@me Capital Plc
0,003p
(-17,81%)
168,35M
OBDOxford Biodynamics Plc
1,20p
(-14,29%)
827,83k
ZENZenith Energy Ltd.
5,25p
(-13,93%)
5,39M
TRPTower Resources Plc
0,0395p
(5,33%)
539,51M
CPXCap-xx Limited
0,1825p
(1,39%)
494M
NTVONativo Resources Plc
0,0019p
(0,00%)
320,16M
DGIDg Innovate Plc
0,0225p
(-13,46%)
208,21M
ENETEthernity Networks Ltd
0,1125p
(2,27%)
207,56M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock